Rapid weight loss and metabolic changes can interact with your cancer survivorship management, so PlexusDx works closely with your existing cancer and endocrinology care to ensure safe, integrated treatment
SLE patients also have lower hematocrit levels compared to healthy individuals and exhibit a higher percentage of PS-exposing erythrocytes, elevated cytosolic Ca 2+ levels, abundance of ROS, and significant erythrocyte shrinkage [327, 328]
Things like side effects, expectations, access, cost and the right support all play a big part in whether treatment continues
Patients continuing treatment beyond six months often see sustained or additional weight loss into month 912, depending on adherence and dose optimization
GLP-1 analogs are often intentionally modified to improve pharmacokinetics, but unintended changes can impact product quality